| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from the issuance of shares in connection with at-the-market offering, net of issuance costs | 0 | - |
| Net cash (used in) provided by financing activities | -13,419 | -12,100 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 13,606 | 14,806 |
| Net decrease in cash, cash equivalents, and restricted cash at the end of the period | -22,859 | -54,701 |
| Cash and cash equivalents at beginning of period | 216,716 | - |
| Cash and cash equivalents at end of period | 193,857 | - |
AMICUS THERAPEUTICS, INC. (FOLD)
AMICUS THERAPEUTICS, INC. (FOLD)